Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Shengji Pharmaceutical is a prominent Chinese pharmaceutical manufacturer based in Jilin City and operates as a key subsidiary of the Xiuzheng Pharmaceutical Group. The company focuses on the production of a diverse range of healthcare products, including chemical pharmaceuticals and Traditional Chinese Medicines (TCM). Its manufacturing facilities are GMP-certified, supporting the production of treatments for cardiovascular diseases, respiratory infections, and gastrointestinal conditions. Jilin Shengji plays a vital role in the supply chain of its parent company, one of China's largest private pharmaceutical enterprises. The company is recognized for its Shengji brand and its commitment to integrating traditional medicinal practices with modern manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Shengji Pharmaceutical.